Acute Leukemia
208
48
64
77
Key Insights
Highlights
Success Rate
87% trial completion
Published Results
28 trials with published results (13%)
Research Maturity
77 completed trials (37% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.8%
12 terminated out of 208 trials
86.5%
-0.1% vs benchmark
5%
10 trials in Phase 3/4
36%
28 of 77 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 77 completed trials
Clinical Trials (208)
Extension of a Study of Allogeneic Hematopoietic Stem Cell Transplantation From One Haplotype Mismatch Related Donor or From an Unrelated Donor to Younger Patients Eligible for Reduced-intensity Conditioning Regimen
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Real World Assessment of Venous Thromboembolic Risk in Hospitalized Patients With Acute Leukemia
Emotion and Symptom-Focused Engagement Trial for Individuals With Acute Leukemia
Brain MRF in Children, Adolescents and Young Adults With Acute Leukemia
Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI
Tools for Reducing Inequity in Acute Leukemia (TRIAL): Beta Testing
Prevention of Oral Mucositis in Adults in With Hematologic Malignancy
Study of 3D189 in Patients With Hematologic Malignancies
Peri-graft Cytokine Profile: Influence of Hematologic Disease and Donor Type
Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem Cell Transplantation
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic Malignancies
HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis
Precision-T: A Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies
A High Intensity Electronic Health Intervention for the Reduction of Learning Disparities in Childhood Cancer Survivors